{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T10:11:58Z","timestamp":1777198318512,"version":"3.51.4"},"reference-count":33,"publisher":"Japanese Circulation Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2020,11,25]]},"DOI":"10.1253\/circj.cj-20-0796","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T22:07:15Z","timestamp":1604614035000},"page":"2244-2252","source":"Crossref","is-referenced-by-count":2,"title":["Impact of Neointimal Condition and Platelet Reactivity on Intrastent Thrombus at Long-Term Follow-up After 2nd- and 3rd-Generation Drug-Eluting Stent Implantation\u3000\u2015 Insights From a Coronary Angioscopy and Pharmacodynamic Study \u2015"],"prefix":"10.1253","volume":"84","author":[{"given":"Takero","family":"Matsuura","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Kindai University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Ueno","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Kindai University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heitaro","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Kindai University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Kindai University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Takase","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Kindai University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Kindai University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Yamaji","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Kindai University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Iwanaga","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Kindai University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichi","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Saiseikai-Tondabayashi Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaku","family":"Nakazawa","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Kindai University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. <i>N Engl J Med<\/i> 2007; 356: 1030\u20131039.","DOI":"10.1056\/NEJMoa067484"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Waksman R, Barbash IM, Dvir D, Torguson R, Ben-Dor I, Maluenda G, et al. Safety and efficacy of the XIENCE V everolimus-eluting stent compared to first-generation drug-eluting stents in contemporary clinical practice. <i>Am J Cardiol<\/i> 2012; 109: 1288\u20131294.","DOI":"10.1016\/j.amjcard.2011.12.019"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study. <i>Lancet<\/i> 2007; 369: 667\u2013678.","DOI":"10.1016\/S0140-6736(07)60314-6"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Stone GW, Rizvi A, Sudhir K, Newman W, Applegate RJ, Cannon LA, et al. Randomized comparison of everolimus- and paclitaxel-eluting stents: 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial. <i>J Am Coll Cardiol<\/i> 2011; 58: 19\u201325.","DOI":"10.1016\/j.jacc.2011.02.022"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Tada T, Byrne RA, Simunovic I, King LA, Cassese S, Joner M, et al. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: Results from a registry of 18,334 patients. <i>JACC Cardiovasc Interv<\/i> 2013; 6: 1267\u20131274.","DOI":"10.1016\/j.jcin.2013.06.015"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ueda Y, Matsuo K, Nishimoto Y, Sugihara R, Hirata A, Nemoto T, et al. In-stent yellow plaque at 1 year after implantation is associated with future event of very late stent failure: The DESNOTE Study (Detect the Event of Very late Stent Failure From the Drug-Eluting Stent Not Well Covered by Neointima Determined by Angioscopy). <i>JACC Cardiovasc Interv<\/i> 2015; 8: 814\u2013821.","DOI":"10.1016\/j.jcin.2014.12.239"},{"key":"7","unstructured":"7. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: Should we be cautious? <i>Circulation<\/i> 2004; 109: 701\u2013705."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kereiakes DJ, Meredith IT, Windecker S, Lee Jobe R, Mehta SR, Sarembock IJ, et al. Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: The EVOLVE II Randomized Trial. <i>Circ Cardiovasc Interv<\/i> 2015; 8: e002372.","DOI":"10.1161\/CIRCINTERVENTIONS.114.002372"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Sarno G, Lagerqvist B, Olivecrona G, Varenhorst C, Danielewicz M, Hambraeus K, et al. Real-life clinical outcomes with everolimus eluting platinum chromium stent with an abluminal biodegradable polymer in patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). <i>Catheter Cardiovasc Interv<\/i> 2017; 90: 881\u2013887.","DOI":"10.1002\/ccd.27030"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hechler B, Cattaneo M, Gachet C. The P2 receptors in platelet function. <i>Semin Thromb Hemost<\/i> 2005; 31: 150\u2013161.","DOI":"10.1055\/s-2005-869520"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Gurbel PA, Bliden KP, Guyer K, Cho PW, Zaman KA, Kreutz RP, et al. Platelet reactivity in patients and recurrent events post-stenting: Results of the PREPARE POST-STENTING Study. <i>J Am Coll Cardiol<\/i> 2005; 46: 1820\u20131826.","DOI":"10.1016\/j.jacc.2005.07.041"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hochholzer W, Trenk D, Bestehorn HP, Fischer B, Valina CM, Ferenc M, et al. Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement. <i>J Am Coll Cardiol<\/i> 2006; 48: 1742\u20131750.","DOI":"10.1016\/j.jacc.2006.06.065"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Suzuki S, Sotomi Y, Kobayashi T, Hamanaka Y, Nakatani S, Shiojima I, et al. Early vessel healing after implantation of biodegradable-polymer and durable-polymer drug-eluting stent: 3-month angioscopic evaluation of the RESTORE registry. <i>Int J Cardiovasc Imaging<\/i> 2019; 35: 973\u2013980.","DOI":"10.1007\/s10554-019-01580-2"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Miyoshi T, Matsuoka H, Kawakami H, Dai K, Sato T, Watanabe K, et al. Assessment of second- and third-generation drug-eluting stents on chronic coronary angioscopy: Multicenter Study on Intra-Coronary AngioScopy After Stent (MICASA) prospective data analysis. <i>Circ J<\/i> 2018; 82: 1830\u20131835.","DOI":"10.1253\/circj.CJ-17-1396"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ichikawa M, Kijima Y, Mishima M. Repetitive angioscopic observations of a sirolimus-eluting stent deployed in a patient with silent chronic thrombotic occlusion. <i>Cardiovasc Interv Ther<\/i> 2012; 27: 201\u2013204.","DOI":"10.1007\/s12928-012-0104-5"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Sato T, Taya Y, Suzuki N, Yuasa S, Kishi S, Koshikawa T, et al. The comparison of early healing 1-month after PCI among CoCr-everolimus-eluting stent (EES), biodegradable polymer (BP)-EES and BP-sirolimus-eluting stent: Insights from OFDI and coronary angioscopy. <i>Int J Cardiol Heart Vasc<\/i> 2018; 20: 40\u201345.","DOI":"10.1016\/j.ijcha.2018.08.001"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ueda Y, Asakura M, Yamaguchi O, Hirayama A, Hori M, Kodama K. The healing process of infarct-related plaques: Insights from 18 months of serial angioscopic follow-up. <i>J Am Coll Cardiol<\/i> 2001; 38: 1916\u20131922.","DOI":"10.1016\/S0735-1097(01)01673-4"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Shibuya M, Fujii K, Hao H, Imanaka T, Saita T, Kawakami R, et al. Atherosclerotic component of the yellow segment after drug-eluting stent implantation on coronary angioscopy: An ex-vivo validation study. <i>Circ J<\/i> 2018; 83: 193\u2013197.","DOI":"10.1253\/circj.CJ-18-0671"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Storey RF, Angiolillo DJ, Patil SB, Desai B, Ecob R, Husted S, et al. Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: The PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudy. <i>J Am Coll Cardiol<\/i> 2010; 56: 1456\u20131462.","DOI":"10.1016\/j.jacc.2010.03.100"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Angiolillo DJ, Shoemaker SB, Desai B, Yuan H, Charlton RK, Bernardo E, et al. Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: Results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study. <i>Circulation<\/i> 2007; 115: 708\u2013716.","DOI":"10.1161\/CIRCULATIONAHA.106.667741"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. Pathological correlates of late drug-eluting stent thrombosis: Strut coverage as a marker of endothelialization. <i>Circulation<\/i> 2007; 115: 2435\u20132441.","DOI":"10.1161\/CIRCULATIONAHA.107.693739"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Nakazawa G, Otsuka F, Nakano M, Vorpahl M, Yazdani SK, Ladich E, et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. <i>J Am Coll Cardiol<\/i> 2011; 57: 1314\u20131322.","DOI":"10.1016\/j.jacc.2011.01.011"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Higo T, Ueda Y, Oyabu J, Okada K, Nishio M, Hirata A, et al. Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent: An angioscopic study. <i>JACC Cardiovasc imaging<\/i> 2009; 2: 616\u2013624.","DOI":"10.1016\/j.jcmg.2008.12.026"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Higo T, Ueda Y, Matsuo K, Nishio M, Hirata A, Asai M, et al. Risk of in-stent thrombus formation at one year after drug-eluting stent implantation. <i>Thromb Res<\/i> 2011; 128: 431\u2013434.","DOI":"10.1016\/j.thromres.2011.05.018"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Okuno S, Ishihara T, Iida O, Asai M, Masuda M, Okamoto S, et al. Association of subclinical intrastent thrombus detected 9 months after implantation of 2nd-generation drug-eluting stent with future major adverse cardiac events: A coronary angioscopic study. <i>Circ J<\/i> 2018; 82: 2299\u20132304.","DOI":"10.1253\/circj.CJ-18-0098"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Ichikawa M, Takei Y, Hamasaki T, Kijima Y. Characterization of patients with angioscopically-detected in-stent mural thrombi: Genetics of clopidogrel responsiveness and generations of drug-eluting stents. <i>Circ J<\/i> 2015; 79: 85\u201390.","DOI":"10.1253\/circj.CJ-14-0639"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Nishimoto Y, Ueda Y, Sugihara R, Murakami A, Ueno K, Takeda Y, et al. Comparison of angioscopic findings among second-generation drug-eluting stents. <i>J Cardiol<\/i> 2017; 70: 297\u2013302.","DOI":"10.1016\/j.jjcc.2016.11.012"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Shimamura K, Ino Y, Kubo T, Nishiguchi T, Tanimoto T, Ozaki Y, et al. Difference of ruptured plaque morphology between asymptomatic coronary artery disease and non-ST elevation acute coronary syndrome patients: An optical coherence tomography study. <i>Atherosclerosis<\/i> 2014; 235: 532\u2013537.","DOI":"10.1016\/j.atherosclerosis.2014.05.920"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. L\u00fcscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC, et al. Drug-eluting stent and coronary thrombosis: Biological mechanisms and clinical implications. <i>Circulation<\/i> 2007; 115: 1051\u20131058.","DOI":"10.1161\/CIRCULATIONAHA.106.675934"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Otsuka F, Vorpahl M, Nakano M, Foerst J, Newell JB, Sakakura K, et al. Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans. <i>Circulation<\/i> 2014; 129: 211\u2013223.","DOI":"10.1161\/CIRCULATIONAHA.113.001790"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Varenne O, Cook S, Sideris G, Kedev S, Cuisset T, Carri\u00e9 D, et al. Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): A randomised single-blind trial. <i>Lancet<\/i> 2018; 391: 41\u201350.","DOI":"10.1016\/S0140-6736(17)32713-7"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ram\u00edrez C, Sabat\u00e9 M, Jimenez-Quevedo P, et al. Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment. <i>Diabetes<\/i> 2005; 54: 2430\u20132435.","DOI":"10.2337\/diabetes.54.8.2430"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Nishikawa M, Takeda Y, Isomura N, Tanigawa T, Nanasato M, Tsukahara K, et al. Association between high platelet reactivity following dual antiplatelet therapy and ischemic events in Japanese patients with coronary artery disease undergoing stent implantation. <i>J Atheroscler Thromb<\/i> 2020; 27: 13\u201324.","DOI":"10.5551\/jat.48934"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/84\/12\/84_CJ-20-0796\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T03:19:31Z","timestamp":1606533571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/84\/12\/84_CJ-20-0796\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,25]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-20-0796","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,25]]}}}